MedRx Co., Ltd (4586.T)

JPY 84.0

(-3.45%)

Revenue Summary of MedRx Co., Ltd

  • MedRx Co., Ltd's latest annual revenue in 2023 was 26 Million JPY , down -51.25% from previous year.
  • MedRx Co., Ltd's latest quarterly revenue in 2024 Q2 was 231.47 Million JPY , down 0.0% from previous quarter.
  • MedRx Co., Ltd reported a annual revenue of 59.48 Million JPY in annual revenue 2022, up 612.36% from previous year.
  • MedRx Co., Ltd reported a annual revenue of 8.35 Million JPY in annual revenue 2021, down -92.74% from previous year.
  • MedRx Co., Ltd reported a quarterly revenue of - JPY for 2024 Q1, down -100.0% from previous quarter.
  • MedRx Co., Ltd reported a quarterly revenue of 250 Thousand JPY for 2023 Q4, down -98.88% from previous quarter.

Annual Revenue Chart of MedRx Co., Ltd (2023 - 2019)

Historical Annual Revenue of MedRx Co., Ltd (2023 - 2019)

Year Revenue Revenue Growth
2023 26 Million JPY -51.25%
2022 59.48 Million JPY 612.36%
2021 8.35 Million JPY -92.74%
2020 115.09 Million JPY -32.24%
2019 169.86 Million JPY 0.0%

Peer Revenue Comparison of MedRx Co., Ltd

Name Revenue Revenue Difference
Pharma Foods International Co., Ltd. 62.14 Billion JPY 99.958%
Takeda Pharmaceutical Company Limited 4263.76 Billion JPY 99.999%
Sumitomo Pharma Co., Ltd. 314.55 Billion JPY 99.992%
Shionogi & Co., Ltd. 435.08 Billion JPY 99.994%
Wakamoto Pharmaceutical Co.,Ltd. 7.73 Billion JPY 99.664%
Nippon Shinyaku Co., Ltd. 148.25 Billion JPY 99.982%
Kaken Pharmaceutical Co., Ltd. 72.04 Billion JPY 99.964%
Eisai Co., Ltd. 741.75 Billion JPY 99.996%
Morishita Jintan Co., Ltd. 12.4 Billion JPY 99.79%
Hisamitsu Pharmaceutical Co., Inc. 141.7 Billion JPY 99.982%
Mochida Pharmaceutical Co., Ltd. 102.88 Billion JPY 99.975%
Fuso Pharmaceutical Industries,Ltd. 55.4 Billion JPY 99.953%
Nippon Chemiphar Co., Ltd. 30.74 Billion JPY 99.915%
Tsumura & Co. 150.84 Billion JPY 99.983%
Kissei Pharmaceutical Co., Ltd. 75.57 Billion JPY 99.966%
Torii Pharmaceutical Co., Ltd. 54.63 Billion JPY 99.952%
Towa Pharmaceutical Co., Ltd. 227.93 Billion JPY 99.989%
Fuji Pharma Co., Ltd. 40.88 Billion JPY 99.936%
Zeria Pharmaceutical Co., Ltd. 75.72 Billion JPY 99.966%
KYORIN Holdings, Inc. 119.53 Billion JPY 99.978%
Taiko Pharmaceutical Co.,Ltd. 5.04 Billion JPY 99.484%
Daito Pharmaceutical Co.,Ltd. 46.89 Billion JPY 99.945%
SymBio Pharmaceuticals Limited 5.58 Billion JPY 99.535%
Mizuho Medy Co.,Ltd. 10.98 Billion JPY 99.763%
Solasia Pharma K.K. 617 Million JPY 95.786%
Modalis Therapeutics Corporation - JPY -Infinity%
ASKA Pharmaceutical Holdings Co.,Ltd. 62.84 Billion JPY 99.959%
Sawai Group Holdings Co., Ltd. 176.86 Billion JPY 99.985%
Cyfuse Biomedical K.K. 61.11 Million JPY 57.455%
Toho Holdings Co., Ltd. 1476.71 Billion JPY 99.998%
Koa Shoji Holdings Co.,Ltd. 22.13 Billion JPY 99.883%